Category: News

The Clinical Research of Mistent® Coronary Drug Eluting Stent System

一、Stent Design The biodegradable coating (PLGA polymer combined with sirolimus crystals) was realized based on supercritical fluid technology, which gave birth to the Mistent® coronary drug-eluting stent. It has two distinctive features: “Quick Healing” and “Long-lasting Drug Efficacy”. The biodegradable polymer enables rapid endothelialization and reduces chronic inflammation and the occurrence of stent thrombosis; the […]

PAIRS 2025 | Expanding Horizons, Connecting Globally

We had a fantastic time at PAIRS 2025, held from April 9–12 at the Dubai World Trade Centre! As a company committed to innovation in vascular intervention, Kossel proudly showcased our flagship products from three key product lines: Peripheral Intervention, Coronary Intervention, and Cardiac Electrophysiology. It was a great opportunity to demonstrate our R&D strength […]

Exciting News | Seledora® Coronary Scoring Balloon Catheter Approved!

On March 14, 2025, Seledora® Coronary Scoring Balloon Catheter, developed by Mixin Medtech(Suzhou) Co., Ltd., a subsidiary of Kossel Medtech (Suzhou) Co., Ltd., received approval from the National Medical Products Administration (NMPA) for market launch (Registration No. 20253030586). Kossel’s independently developed Octoparms® II Vena Cava Filter has also been approved by the NMPA today (Registration […]

Good news! Octoparms® Ⅱ Vena Cava Filter Obtained NMPA Certificate！

On March 14, 2025, the Octoparms® II vena cava filter independently developed by Kossel Medtech (Suzhou) Co., Ltd. was approved by the National Drug Administration (NMPA). (registration number is 20253130576). In addition, the Seledora® coronary scoring balloon catheter developed by the subsidiary Mixin Medtech was also approved by the National Medical Products Administration (NMPA) today. […]

An Analysis of the “Long-lasting Efficacy” of the MiStent Stent

The MiStent coronary drug-eluting stent, an important overseas transformation project of Kossel Medtech has officially entered the Chinese market with two major advantages of “rapid healing and long-lasting efficacy”, providing a new clinical option for PCI surgeries. This issue will introduce the design story behind the realization of the “long-lasting efficacy” function of the MiStent […]

Mistent® Fast Healing” in Stent Analysis

Mistent® coronary drug-eluting stent system, as an important overseas transformation project of Kossel Medtech, has officially launched in the Chinese market with two advantages of “fast healing and long efficacy”, providing a new clinical choice for PCI surgery. This article brings you the design story behind the realization of the “fast healing” function of Mistent® […]

Good News 丨 Selethru® PTCA Balloon Dilatation Catheter and Selethru® NC PTCA Non – compliant Balloon Dilatation Catheter Approved in India, Accelerating Expansion in the Asian Market!

At the beginning of 2025, good news keeps coming. The two products, Selethru® PTCA Balloon Dilatation Catheter and Selethru® NC PTCA Balloon Dilatation Catheter independently developed by Kossel, were approved for listing in Pakistan at the end of 2024 and then approved for listing by the Central Drugs Standard Control Organization (CDSCO) of India. India […]

Strong Debut of MiStent® Coronary Drug-eluting Stent System

MiStent® coronary drug-eluting stent system, as an important overseas transformation project of Kossel Medtech (Suzhou) Co., Ltd., has officially landed in the Chinese market with two advantages of “fast healing and long efficacy”, providing a new clinical choice for PCI surgery. Fast healing: Thin-wall stent + degradable coating, rapid endothelialization, reduce chronic inflammation and stent thrombosis; Long […]